Intra-Arterial Gemcitabine vs Intravenous Gemcitabine: Pharmacokinetic and Pharmacodynamic Sub-study of the TIGeR-PaC Phase 3 Clinical Trial Presented at ASCO Gastrointestinal Cancers Symposium 2026, January 2026

A Moffitt Cancer Center patient with locally advanced pancreatic cancer is regaining parts of his daily life after a treatment designed to deliver chemotherapy near the tumor.

A targeted drug-delivery device may help some pancreatic cancer patients get chemotherapy with fewer body-wide side effects.

For 70-year-old Roberta Luna, tending to her garden is therapy — especially trimming rosemary, its purple blooms matching the color she wears every day for pancreatic cancer awareness: purple.